Leslie S.  Heisz net worth and biography

Leslie Heisz Biography and Net Worth

Leslie Stone Heisz serves as Independent Director of the Company. Ms. Heisz’s career in the banking industry, in-depth knowledge of capital markets, and previous public company board and audit committee experience enhances our Board’s ability to effectively oversee financial reporting, enterprise and operational risk management, as well as corporate finance, tax, treasury, and governance matters.

What is Leslie S. Heisz's net worth?

The estimated net worth of Leslie S. Heisz is at least $2.41 million as of February 8th, 2024. Ms. Heisz owns 26,980 shares of Edwards Lifesciences stock worth more than $2,414,170 as of April 16th. This net worth evaluation does not reflect any other investments that Ms. Heisz may own. Learn More about Leslie S. Heisz's net worth.

How do I contact Leslie S. Heisz?

The corporate mailing address for Ms. Heisz and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected]. Learn More on Leslie S. Heisz's contact information.

Has Leslie S. Heisz been buying or selling shares of Edwards Lifesciences?

Leslie S. Heisz has not been actively trading shares of Edwards Lifesciences in the last ninety days. Most recently, Heisz Leslie Stone sold 7,056 shares of the business's stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $86.45, for a transaction totalling $609,991.20. Following the completion of the sale, the director now directly owns 26,980 shares of the company's stock, valued at $2,332,421. Learn More on Leslie S. Heisz's trading history.

Who are Edwards Lifesciences' active insiders?

Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.

Are insiders buying or selling shares of Edwards Lifesciences?

In the last year, insiders at the medical research company sold shares 60 times. They sold a total of 768,312 shares worth more than $62,771,727.15. The most recent insider tranaction occured on April, 8th when VP Jean-Luc M Lemercier sold 14,400 shares worth more than $1,329,408.00. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.

Information on this page was last updated on 4/8/2024.

Leslie S. Heisz Insider Trading History at Edwards Lifesciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/8/2024Sell7,056$86.45$609,991.2026,980View SEC Filing Icon  
8/10/2023Sell3,303$78.87$260,507.6126,980View SEC Filing Icon  
2/16/2023Sell9,671$76.82$742,926.2227,480View SEC Filing Icon  
4/23/2021Sell6,707$97.52$654,066.6429,272View SEC Filing Icon  
See Full Table

Leslie S. Heisz Buying and Selling Activity at Edwards Lifesciences

This chart shows Heisz Leslie Stone's buying and selling at Edwards Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Edwards Lifesciences Company Overview

Edwards Lifesciences logo
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $90.06
Low: $87.87
High: $90.40

50 Day Range

MA: $90.07
Low: $84.87
High: $95.56

2 Week Range

Now: $90.06
Low: $60.57
High: $96.12

Volume

2,640,500 shs

Average Volume

3,888,942 shs

Market Capitalization

$54.21 billion

P/E Ratio

39.16

Dividend Yield

N/A

Beta

1.05